skip to main content

Navigating Aortic Fragility and Seizure Risk in a Child with Marfan Syndrome Undergoing Hypospadias Repair: The Potential of Dexmedetomidine-Based Anesthesia–A Case Report

Department of Anesthesiology and Intensive Care, Faculty of Medicine, Universitas Jenderal Soedirman, Indonesia, Indonesia

Received: 30 Mar 2026; Revised: 9 Jul 2026; Accepted: 2 Nov 2026; Available online: 2 Nov 2026.
Open Access Copyright 2021 JAI (Jurnal Anestesiologi Indonesia)
Creative Commons License This work is licensed under a Creative Commons Attribution 4.0 International License.

Citation Format:
Cover Image
Abstract

Marfan syndrome poses significant anesthetic risks, including cardiovascular instability and tissue fragility, which are further complicated in pediatric patients with epilepsy. We present the anesthetic management of a 13-year-old boy with Marfan syndrome and controlled epilepsy undergoing elective urethroplasty. To prioritize hemodynamic stability for aortic protection and prevent perioperative seizures, general anesthesia was induced and maintained with sevoflurane and a continuous dexmedetomidine infusion (loading dose 0.5 µg/kg; maintenance 0.2 µg/kg/h). This multimodal approach provided effective sympatholysis and analgesia without utilizing neuraxial blockade. Intraoperative hemodynamics remained stable, and the patient was extubated smoothly without coughing or agitation, followed by an uncomplicated discharge on the second postoperative day. Dexmedetomidine demonstrated efficacy as a pivotal adjunct in this complex case, enabling a non-neuraxial strategy and ensuring a smooth emergence to minimize perioperative morbidity in high-risk pediatric patients with connective tissue and neurological comorbidities

Note: This article has supplementary file(s).

Fulltext View|Download |  Cover Letter
Cover Letter
Subject
Type Cover Letter
  Download (48KB)    Indexing metadata
 Copyright Transfer Agreement
Copyright Form
Subject
Type Copyright Transfer Agreement
  Download (27KB)    Indexing metadata
Email colleagues
Keywords: Dexmedetomidine; epilepsy; general anesthesia; hypospadias; Marfan syndrome; pediatric anesthesia

Article Metrics:

  1. Coelho SG, Almeida AG. Marfan syndrome revisited: From genetics to the clinic. Revista Portuguesa de Cardiologia. 2020 Apr;39(4):215–26
  2. Marelli S, Micaglio E, Taurino J, Salvi P, Rurali E, Perrucci GL, et al. Marfan Syndrome: Enhanced Diagnostic Tools and Follow-up Management Strategies. Diagnostics. 2023 Jul 5;13(13):2284
  3. Lazea C, Bucerzan S, Crisan M, Al-Khzouz C, Miclea D, Șufană C, et al. Cardiovascular manifestations in Marfan syndrome. Med Pharm Rep. 2021;94:25–7
  4. Pūkas A, Stankutė D, Gudaitytė J. Anaesthetic Management of a Patient with Marfan Syndrome Undergoing Elective Ventral Hernia Repair. Healthcare. 2025 Dec 23;14(1):34
  5. Lin R, Ansermino JM. Dexmedetomidine in paediatric anaesthesia. BJA Educ. 2020 Oct;20(10):348–53
  6. Janse van Rensburg E, Indiveri L, Mogane P. The Perioperative Use of Dexmedetomidine in Paediatric Patients. Children. 2025 May 28;12(6):690
  7. Zhang X, Fan Z, He D, Liu Y, Shi X, Zhang H. Effectiveness of dexmedetomidine as a premedication for pediatric patients undergoing outpatient dental surgery under general anaethesia-systematic review and meta-analysis. PeerJ. 2025 Mar 31;13:e19216
  8. Loeys BL, Dietz HC, Braverman AC, Callewaert BL, De Backer J, Devereux RB, et al. The revised Ghent nosology for the Marfan syndrome: Table 1. J Med Genet. 2010 Jul 30;47(7):476–85

Last update:

No citation recorded.

Last update: 2026-11-07 02:39:53

No citation recorded.